FDA scientists opposed the Trump administration's move to ease peptides access

Left-leaning 2

Only this side used: controversialosteoporosisunapprovedtemporary

• The Guardian left

  FDA scientists opposed Trump administration’s move to ease peptide access
• The Washington Post left

  The Trump administration released its plans for the temporary sale of six unapproved and controversial peptides that have been marketed but untested to treat maladies including osteoporosis, insomnia and migraines.
  

Center 2

Only this side used: effort

• WSLS center

  FDA scientists opposed the Trump administration's effort to ease peptides access
• LancasterOnline center

  FDA scientists opposed the Trump administration's move to ease peptides access

Right-leaning 0

No right-leaning outlet we follow has covered this.